Does Ambetter Cover Ozempic? Criteria, Copay, How to Appeal
Ambetter covers Ozempic for type 2 diabetes on its drug list, usually with prior authorization. Ozempic is approved for type 2 diabetes; kidney disease with type 2 diabetes; and heart risk, not weight loss, so the plan judges it on those uses.
- For type 2 diabetes
- Covered on formulary
- Prior authorization
- Required
- For weight loss
- Excluded
- Self-pay if denied
- $149 a month
Ozempic in brief
Its half-life is about 1 week. After 7 d, half has gone, while about 3% remains after five half-lives (35 d).
In SUSTAIN 1 with type 2 diabetes, people lost 4.7 kg over 30 weeks, versus 1.2 kg for those on placebo.
Prices each month, in US dollars: the list price and self-pay offers, all taken from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.
Does Ambetter cover Ozempic?
Ambetter marketplace plans exclude Wegovy for weight management, but uses for heart-risk and MASH may be approved if you meet the criteria.
| Medicine | Approved for | Status | Prior authorization |
|---|---|---|---|
| Type 2 diabetes; kidney disease with type 2 diabetes; and heart risk | Covered on formulary | Required |
Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.
The published policy
Ambetter operates as an ACA marketplace insurer
- Benefit exclusion: Wegovy for weight management
See the full policy at ambetterhealth.com.
Source: ambetterhealth.com.
Prior authorization checklist
- In your chart: type 2 diabetes, or an approved Ozempic use that involves heart risk and kidney disease with type 2 diabetes.
- Along with the diabetes medicines you have already tried, include your recent A1C results.
- Sender: Your prescriber files the prior authorization, not you.
After a denial: how to appeal the decision
| Denial reason | What to send or ask |
|---|---|
| Prior authorization missing | Using the plan's form, your prescriber submits recent A1C plus your type 2 diabetes diagnosis. |
| The plan wants another drug first | Ask the plan which drugs it prefers you try first. Send your records for drugs you have already tried. |
| The drug is not on the plan's list | Ask the plan to identify its preferred GLP-1 alternative, and request a formulary exception. |
- Get the denial letter. It shows the exact rule you did not meet.
- Your prescriber files the appeal with notes from your chart that answer that rule.
- If the plan's appeal fails, ask an independent reviewer for an external review.
Plan and State differences
| Plan | For type 2 diabetes | Prior authorization |
|---|---|---|
| Medicare | Covered by Part D plans | Required |
| Medicaid | Covered | Required |
| Covered on formulary | Required | |
| Covered on formulary | Required | |
| Covered on formulary | Required | |
| Covered on formulary | Required | |
| Covered on formulary | Required | |
| TRICARE | Covered with PA | Required |
| Covered with PA | Required | |
| Covered on formulary | Required | |
| Express Scripts | Covered on formulary | Required |
| Optum Rx | Covered on formulary | Required |
| Covered by Part D plans | Required | |
| VA (Veterans Health Administration) | Covered | Required |
| Covered | Required | |
| ACA Marketplace plans | Common | Required |
| Covered on formulary | Not listed |
Medicaid rules differ by state. Today, 10 states cover GLP-1s for weight loss. See all state rules.
Other options if coverage is denied
| Route | Who it is for | What you pay | Limits and dates |
|---|---|---|---|
| NovoCare Pharmacy: Ozempic pill (from 1.5 mg) | Self-pay, no insurance needed | $149 a month | Not listed |
| TrumpRx listing (pen, starting) | Self-pay only, not with insurance | $199 a month | The offer runs from November 17, 2025 to December 31, 2026 |
| Novo Nordisk PAP | Income for your household must stay at or below 200% of the federal poverty level | Free if approved | Income limit: 200% of the poverty level for the household. Not eligible if you hold Medicare drug coverage |
Prices checked November 2026. A link on each price takes you to its source page.
Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.